According to World Health Organization (WHO), more that 37 million people worldwide are living with Human immunodeficiency virus (HIV) infection, whereas the more than 70% of all the HIV infected people live in sub-Saharan African region. CD4 T cell count and viral load in whole blood are important biomarkers for HIV diagnostics and treatment monitoring, however these assays require access to state-of-the-art labs and trained technicians. Further, currrent methods are expensive and not affordable by developing world. The resource-constrained regions of the world lack state-of-the-art laboratory equipment and trained technicians. There is a need to develop a disposable, easy-to-use and an inexpensive platform that can efficiently detect disease using a small volume of whole blood. We have developed a microfluidic platform that can detect disease biomarkers and count cells at resource-constrained settings

Low-cost bioassay developement for resource-constrained settings

255th National Meeting (2018)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.